Breast
Use of DiviTum -TKa as a biomarker assay for CDK4/6 inhibitor medication compliance and drug-drug interactions assessment and intervention in HR-positive metastatic breast cancer patients
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this study is to assess optimal blood levels of this medication in the blood, and to assess medical compliance and drug-drug interactions.
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated10/02/2024
- Study HIC#2000033797